Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Kramer

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Therapeutics|July 1, 1995
Effect of Food on the Pharmacokinetics and Pharmacodynamics of TorsemideWilliam G. Kramer
Clinical Therapeutics|December 2, 2017
Comparative Bioavailability of Hydroxyprogesterone Caproate Administered via Intramuscular Injection or Subcutaneous Autoinjector in Healthy Postmenopausal Women: A Randomized, Parallel Group, Open-label StudyJulie Krop, William G Kramer
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 30, 2019
Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White RabbitsSidney L Weiss, William G Kramer
Journal of Clinical Pharmacology|December 3, 2014
Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairmentRosarelis Torres, William G Kramer, Paolo Baroldi
Clinical Kidney Journal|July 5, 2021
Evaluation of potential drug interactions with sodium zirconium cyclosilicate: a single-center, open-label, one sequence crossover study in healthy adultsMats Någård, William G Kramer, David W Boulton
British Journal of Clinical Pharmacology|January 19, 2010
The effects of sitaxentan on sildenafil pharmacokinetics and pharmacodynamics in healthy subjectsFiona Stavros, William G Kramer, Martin R Wilkins
Cardiovascular Diseases|September 1, 1981
Pharmacodynamics of fentanyl citrate in patients undergoing aortocoronary bypassAdolph J Koska, Alexander Romagnoli, William G. Kramer
American Journal of Therapeutics|February 7, 2015
Absolute Bioavailability of TasimelteonRosarelis Torres, Marlene A Dressman, William G Kramer, et al.
Clinical Drug Investigation|December 12, 2012
Pharmacokinetic profile of liposome bupivacaine injection following a single administration at the surgical siteDeeDee Hu, Erol Onel, Neil Singla, et al.
Clinical Pharmacokinetics|March 27, 2014
The pharmacokinetics and pharmacodynamics of TOL101, a murine IgM anti-human αβ T cell receptor antibody, in renal transplant patientsDaniel R Getts, William G Kramer, Alexander C Wiseman, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Therapeutics|July 1, 1995
Effect of Food on the Pharmacokinetics and Pharmacodynamics of TorsemideWilliam G. Kramer
Clinical Therapeutics|December 2, 2017
Comparative Bioavailability of Hydroxyprogesterone Caproate Administered via Intramuscular Injection or Subcutaneous Autoinjector in Healthy Postmenopausal Women: A Randomized, Parallel Group, Open-label StudyJulie Krop, William G Kramer
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 30, 2019
Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White RabbitsSidney L Weiss, William G Kramer
Journal of Clinical Pharmacology|December 3, 2014
Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairmentRosarelis Torres, William G Kramer, Paolo Baroldi
Clinical Kidney Journal|July 5, 2021
Evaluation of potential drug interactions with sodium zirconium cyclosilicate: a single-center, open-label, one sequence crossover study in healthy adultsMats Någård, William G Kramer, David W Boulton
British Journal of Clinical Pharmacology|January 19, 2010
The effects of sitaxentan on sildenafil pharmacokinetics and pharmacodynamics in healthy subjectsFiona Stavros, William G Kramer, Martin R Wilkins
Cardiovascular Diseases|September 1, 1981
Pharmacodynamics of fentanyl citrate in patients undergoing aortocoronary bypassAdolph J Koska, Alexander Romagnoli, William G. Kramer
American Journal of Therapeutics|February 7, 2015
Absolute Bioavailability of TasimelteonRosarelis Torres, Marlene A Dressman, William G Kramer, et al.
Clinical Drug Investigation|December 12, 2012
Pharmacokinetic profile of liposome bupivacaine injection following a single administration at the surgical siteDeeDee Hu, Erol Onel, Neil Singla, et al.
Clinical Pharmacokinetics|March 27, 2014
The pharmacokinetics and pharmacodynamics of TOL101, a murine IgM anti-human αβ T cell receptor antibody, in renal transplant patientsDaniel R Getts, William G Kramer, Alexander C Wiseman, et al.
Pageof 4